-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R5dVUMJZSVDY3DbNkZCuLFHe2OzvrGeUCzpsT6zsI1EAho+hhYHmU0W7Xwwuh5oU
 Pbo9BlQtv3/+48kHvO8tbw==

<SEC-DOCUMENT>0000950136-02-001549.txt : 20020520
<SEC-HEADER>0000950136-02-001549.hdr.sgml : 20020520
<ACCEPTANCE-DATETIME>20020520161657
ACCESSION NUMBER:		0000950136-02-001549
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20020520

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLARUS CORP
		CENTRAL INDEX KEY:			0000913277
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				581972600
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24277
		FILM NUMBER:		02657783

	BUSINESS ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024
		BUSINESS PHONE:		7702913900

	MAIL ADDRESS:	
		STREET 1:		3970 JOHNS CREEK CT
		STREET 2:		STE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SQL FINANCIALS INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19980911

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KANDERS WARREN B
		CENTRAL INDEX KEY:			0000935577
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
		BUSINESS PHONE:		2035529600

	MAIL ADDRESS:	
		STREET 1:		C/O THE LANGER BIOMEDICS GROUP INC
		STREET 2:		450 COMMACK RD
		CITY:			DEER PARK
		STATE:			NY
		ZIP:			11729
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>file001.txt
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 14A

                PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                                (AMENDMENT NO. )

Filed by the Registrant [ ]    Filed by a Party other than the Registrant [X]

Check the appropriate box:

[ ]   Preliminary Proxy Statement

[ ]   Confidential, For Use of the Commission Only (as permitted by
      Rule 14a-6(e)(2))

[ ]   Definitive Proxy Statement

[X]   Definitive Additional Materials

[ ]   Soliciting Material Pursuant to Rule 14a-12

                               CLARUS CORPORATION
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                WARREN B. KANDERS
                                BURTT R. EHRLICH
                                NICHOLAS SOKOLOW
    (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of filing fee (Check the appropriate box):

[X]    No fee required.

[ ]    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

   (1) Title of each class of securities to which transaction applies:

   (2) Aggregate number of securities to which transaction applies:

   (3) Per unit price or other underlying value of transaction computed pursuant
       to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
       is calculated



<PAGE>


       and state how it was determined):

   (4) Proposed maximum aggregate value of transaction:

   (5) Total fee paid:

[ ]    Fee paid previously with preliminary materials.

[ ]    Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

   (1) Amount previously paid:

   (2) Form, Schedule or Registration Statement No.:

   (3) Filing Party:

   (4) Date Filed:







<PAGE>


                        KANDERS NOMINEES RECEIVE SUPPORT
                           FROM COLUMBIA PARTNERS LLC,
                             A 5% CLARUS STOCKHOLDER

                         ------------------------------

          TO VOTE GREEN, CALL MACKENZIE PARTNERS, INC. AT 800-322-2885

        ----------------------------------------------------------------

Greenwich, Connecticut, May 20, 2002: Warren B. Kanders, Burtt R. Ehrlich and
Nicholas Sokolow (the "Kanders Nominees"), who collectively own approximately
5.6% of the outstanding common stock of Clarus Corporation (NASDAQ: CLRS)
("Clarus"), welcome the announcement of Columbia Partners LLC ("Columbia") of
Columbia's support of the Kanders Nominees at the upcoming annual meeting of
stockholders of Clarus. Columbia owns just under 5% of the outstanding shares of
Clarus.

A spokesperson for Columbia stated, "After carefully considering all nominees to
the Clarus Board, we believe that the best interests of the shareholders that we
represent are served by voting on behalf of the Kanders Nominees. We are pleased
to support the Kanders Nominees in their bid to be elected to Clarus' Board."

Warren Kanders said, "We are gratified by the support from Columbia and other
large institutional stockholders. We will press management to consummate a sale
of the Company for the best possible price."

THE KANDERS NOMINEES STRONGLY RECOMMEND THAT YOU VOTE TO PROTECT YOUR INTEREST
AS A CLARUS STOCKHOLDER BY SIGNING, DATING AND RETURNING THE GREEN PROXY CARD.

Messrs. Kanders, Ehrlich and Sokolow have filed a definitive proxy statement
(the "proxy statement") with the Securities and Exchange Commission (the
"Commission"). Please read the proxy statement carefully because it contains
important information, including information regarding Messrs. Kanders, Ehrlich
and Sokolow. You may obtain a free copy of this press release and the proxy
statement at the Commission's website at A free copy of this press release and
the proxy statement may also be obtained from MacKenzie Partners, Inc. at 105
Madison Avenue, New York, NY 10016, toll free telephone number: (800) 322-2885.












</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
